共 142 条
[1]
Webber L(2016)ESHRE guideline: management of women with premature ovarian insufficiency Hum Reprod 31 926-937
[2]
Davies M(2016)Premature ovarian insufficiency: the context of long-term effects J Endocrinol Invest 39 983-990
[3]
Anderson R(2008)Spontaneous premature ovarian failure: management challenges Gynecol Endocrinol 24 273-279
[4]
Podfigurna-Stopa A(2000)Premature ovarian failure: etiology and prospects Gynecol Endocrinol 14 292-302
[5]
Czyzyk A(2014)Premature ovarian failure: diagnosis and treatment Clin Exp Obstet Gynecol 41 659-661
[6]
Grymowicz M(2021)The therapeutic effect of stem cells on chemotherapy-induced premature ovarian failure Curr Mol Med 21 376-384
[7]
Kalu E(2018)Role of autologous bone marrow-derived stem cell therapy for follicular recruitment in premature ovarian insufficiency: review of literature and a case report of world's first baby with ovarian autologous stem cell therapy in a perimenopausal woman of age 45 year J Hum Reprod Sci 11 125-130
[8]
Panay N(2021)Evaluation of safety, feasibility and efficacy of intra-ovarian transplantation of autologous adipose derived mesenchymal stromal cells in idiopathic premature ovarian failure patients: non-randomized clinical trial, phase I, first in human J Ovarian Res 14 5-716
[9]
Laml T(2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement PLoS Med 6 e1000097-1557
[10]
Schulz-Lobmeyr I(2014)SYRCLE's risk of bias tool for animal studies BMC Med Res Methodol 14 43-255